Search results for Anti-Cytokeratin 8

Anti-Cytokeratin 8 antibody [SP102], prediluted, Abcam, AB228149

Anti-Cytokeratin 8+18 antibody [5D3], Abcam, AB17139

This antibody stains simple and glandular epithelium. It can be useful for the identification of adenocarcinomas and most squamous cell carcinomas.

FITC Anti-Cytokeratin 8 antibody [C-43], Abcam, AB176533

Anti-Cytokeratin 8 + 18 + 19 antibody [2A4], Abcam, AB41825

Balb/c spleen cells used to produce hybridoma. This antibody recognizes cytokeratins 8, 18 and 19 typical for simple epithelial cells.

Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker, Abcam, AB53280

Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P, IP, WB in human, mouse, rat samples. Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) has been cited over 135 times in peer reviewed journals and is trusted by the scientific community. Abcams high quality manufacturing and validation processes ensure Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. The specificity of Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) has been confirmed by testing in knockout samples. Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) has 9 independent reviews from customers. Anti-Cytokeratin 8 antibody [EP1628Y] - Cytoskeleton Marker (ab53280) specifically detects Cytokeratin 8 (UniProt ID: P05787; Molecular weight: 54kDa) and is sold in 100 uL and 1 mL selling sizes. Conjugation-ready, carrier free format available for antibody clone EP1628Y - ab217173 . Antibody clone EP1628Y is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, PE, Alexa Fluor® 45 ( ab192467 , ab192468 , ab19394 , ab29297 , ab21139 ). Cytokeratin 8 (CK8) is a type II cytoskeletal keratin protein that is used as a diagnostic marker to differentiate various carcinomas. CK8 is involved in cell signaling, attachment, and stress adaptation, which are crucial for cancer cell survival and progression. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Species reactivity Rat: We have preliminary internal testing data to indicate this antibody may not react with this species. Please contact us for more information.

Anti-Cytokeratin 8 antibody [M20] - Cytoskeleton Marker, Abcam, AB9023

What is this antibody validated in? Anti-Cytokeratin 8 antibody [M20] - Cytoskeleton Marker (ab9023) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Rabbit, Rat samples. Trusted by the scientific community Anti-Cytokeratin 8 [M20] - Cytoskeleton Marker (ab9023) was first used in a scientific publication in 2003 and has been cited over 40 times in peer-reviewed journals. Reviewed by scientists Anti-Cytokeratin 8 [M20] - Cytoskeleton Marker (ab9023) has over 10 independent reviews from customers. Specificity confirmed The specificity of Anti-Cytokeratin 8 antibody [M20] - Cytoskeleton Marker (ab9023) has been confirmed by Western blot testing in Cytokeratin 8 Knockout HeLa cell line, ab255400 .

Anti-Cytokeratin 8 antibody [SP102] - C-terminal, Abcam, AB227644

Anti-Cytokeratin 8 (phospho S23) antibody [EP1629Y], Abcam, AB76584

This product has switched from a hybridoma to recombinant production method on 23rd February 2024. Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Cytokeratin 8 (phospho S431) antibody [EP1630], Abcam, AB109452

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

Anti-Cytokeratin 8 (phospho S432) antibody[RP23040156], Abcam, AB313459

What are recombinant multiclonals? Recombinant multiclonals are a mixture of recombinant antibodies co-expressed from a library of heavy and light chains. They offer several advantages including: - The sensitivity of polyclonal antibodies by recognising multiple epitopes - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production View our range of recombinant multiclonal antibodies .